-+ 0.00%
-+ 0.00%
-+ 0.00%

Lantern Pharma Q1 EPS $(0.30) Beats $(0.36) Estimate

Benzinga·05/15/2026 20:01:59
Listen to the news
Lantern Pharma (NASDAQ:LTRN) reported quarterly losses of $(0.30) per share which beat the analyst consensus estimate of $(0.36) by 16.67 percent. This is a 28.57 percent increase over losses of $(0.42) per share from the same period last year.